Amandine Segot

Lausanne, VD, Switzerland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Initial management of immune thrombocytopenia

Initial management of immune thrombocytopenia

Journal: Revue medicale suisse

Published: September 02, 2026

Correspondance: Venetoclax combined with FLAG-based chemotherapy induces rapid and deep responses in early T-cell precursor lymphoblastic leukemia/lymphoma. Report of two cases and review of the literature.

Correspondance: Venetoclax combined with FLAG-based chemotherapy induces rapid and deep responses in early T-cell precursor lymphoblastic leukemia/lymphoma. Report of two cases and review of the literature.

Journal: Annals of hematology

Published: October 08, 2025

Initial management of acute leukemia and its complications

Initial management of acute leukemia and its complications

Journal: La Revue de medecine interne

Published: December 23, 2024

Tocilizumab and immune signatures for targeted management of cytokine release syndrome in immune checkpoint therapy.

Tocilizumab and immune signatures for targeted management of cytokine release syndrome in immune checkpoint therapy.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: October 09, 2024

Cryptic KMT2A::MLLT10 Rearrangement in a Highly Aggressive Acute Myeloid Leukemia.

Cryptic KMT2A::MLLT10 Rearrangement in a Highly Aggressive Acute Myeloid Leukemia.

Journal: International journal of laboratory hematology

Published: September 17, 2024

Classic Hodgkin Lymphoma: The LYSA pragmatic guidelines.

Classic Hodgkin Lymphoma: The LYSA pragmatic guidelines.

Journal: European journal of cancer (Oxford, England : 1990)

Published: July 25, 2024

Primary diffuse large B-cell lymphoma of the central nervous system identified with CSF biomarkers.

Primary diffuse large B-cell lymphoma of the central nervous system identified with CSF biomarkers.

Journal: BMC neurology

Published: April 03, 2024

Deep blue.

Deep blue.

Journal: Blood

Published: March 21, 2024

Recognizing and managing side effects of tyrosine kinase inhibitors in chronic myeloid leukemia

Recognizing and managing side effects of tyrosine kinase inhibitors in chronic myeloid leukemia

Journal: Revue medicale suisse

Published: November 15, 2023

Long-standing thrombocytosis often precedes thromboembolic complications heralding the diagnosis of essential thrombocythemia.

Long-standing thrombocytosis often precedes thromboembolic complications heralding the diagnosis of essential thrombocythemia.

Journal: European journal of internal medicine

Published: August 28, 2022

Response-adjusted regimen combining ruxolitinib, etoposide and dexamethasone (adRED) in adult patients with acute myeloid leukemia-associated hemophagocytic lymphohistiocytosis: a single-center pilot trial.

Response-adjusted regimen combining ruxolitinib, etoposide and dexamethasone (adRED) in adult patients with acute myeloid leukemia-associated hemophagocytic lymphohistiocytosis: a single-center pilot trial.

Journal: Haematologica

Published: April 28, 2022

Low COAT platelets are frequent in patients with bleeding disorders of unknown cause (BDUC) and can be enhanced by DDAVP.

Low COAT platelets are frequent in patients with bleeding disorders of unknown cause (BDUC) and can be enhanced by DDAVP.

Journal: Journal of thrombosis and haemostasis : JTH

Published: December 30, 2021

Showing 1-12 of 19

Last Updated: 09/26/2026